This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Oblique Therapeutics Ab. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Max Davidson - Innovator in Multi-Protease Methods
Introduction
Max Davidson is a notable inventor based in Gothenburg, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of methods for identifying protein epitopes.
Latest Patents
Max Davidson holds a patent for a Multi-protease method. This invention relates to methods of identifying an epitope on a protein that can be bound by an antibody. The methods typically involve a step of limited or restricted proteolysis of a protein using a single first protease or a combination of first proteases. Additionally, a further proteolysis step is conducted using a single second protease or a combination of second proteases. The invention also encompasses identified epitopes and antibodies that bind to these epitopes.
Career Highlights
Max Davidson is associated with Oblique Therapeutics AB, where he applies his expertise in protease methods to advance therapeutic solutions. His work has the potential to impact various applications in medical research and treatment.
Collaborations
Max collaborates with esteemed colleagues, including Owe Orwar and Carolina Trkulja, who contribute to the innovative environment at Oblique Therapeutics AB.
Conclusion
Max Davidson's work in multi-protease methods exemplifies the innovative spirit in biotechnology. His contributions are paving the way for advancements in antibody research and therapeutic applications.